COSMO Pharmaceuticals Aktie
66,50EUR | -1,00EUR | -1,48% |
WKN DE: A2AJ68 / ISIN: NL0011832936
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 234 | 265 | 290 | 295 | 325 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,30 | 0,25 | 0,24 | 0,35 | 0,28 |
Bilanz (in Mio. CHF) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 329 | 273 | 286 | 302 | 95 |
Summe Anlagevermögen | 307 | 371 | 549 | 448 | 420 |
Summe Aktiva | 636 | 645 | 835 | 750 | 515 |
Bilanz (in Mio. CHF) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 208 | 220 | 311 | 299 | 116 |
Summe Eigenkapital | 428 | 425 | 524 | 451 | 399 |
Summe Passiva | 636 | 645 | 835 | 750 | 515 |
Adresse
Riverside II, 2 Dublin | |
Telefon | +353 (1) 8170370 |
Fax | +353 (1) 8230718 |
Internet | http://www.cosmopharma.com |
Management
Alessandro Della Chà
Chairman |
Davide Malavasi
Director-Qualified Person & Technical |
Diana Harbort
President-Dermatology |
Dominika Spilarova
Chief of Staff & Chief Strategy Officer |
Egle Gedrimaite
Head-Global Business Development |
Giovanni di Napoli
Chief Executive Officer & Executive Director |
Giulio Evangelisti
Senior VP-Manufacturing, Service & Security |
Hazel Winchester
Head-Investor Relations |
John O'Dea
Non-Executive Director |
Luigi Longo
Chief Scientific Office |
Marco Lecchi
Chief Operating Officer |
Maria Grazia Roncarolo
Independent Non-Executive Director |
Mauro Severino Ajani
Non-Executive Director |
Nhan Ngo Dinh
President-Cosmo Intelligent Medical Devices |
Niall Donnelly
Executive Director & Chief Sustainability Officer |
Paolo Lanzarotti
Manager-R&D Analytical Development |
Roberto Villa
Chief Manufacturing Officer |
Silvana Perretta
Non-Executive Director |
Svetlana Sigalova
Chief Financial Officer |